CSL Behring (Australia) Pty Ltd
$6.32 billion
Lifetime federal contract value awarded across 12 contract notices.
- ABN
- 48160734761
- Country
- AUSTRALIA
- State
- VIC
Awarded by financial year
- 2014-15$568,838,746
- 2015-16$0
- 2016-17$197,003,646
- 2017-18$3,351,400,190
- 2018-19$0
- 2019-20$0
- 2020-21$1,874,602,219
- 2021-22$0
- 2022-23$254,215,600
- 2023-24$0
- 2024-25$73,601,833
- 2025-26$54,317
Top agencies awarded to this supplier
- National Blood Authority$6,319,662,233
- Department of Defence$54,317
Contracts (12)
Click any CN ID to verify the contract notice on AusTender.
- $23,279Department of DefencePharmaceutical ProductsPublished 28 Apr 2026
- $10,346Department of DefencePathology ProductsPublished 20 Apr 2026
- $10,346Department of DefencePathology ProductsPublished 13 Oct 2025
- $10,346Department of DefencePathology ProductsPublished 24 Sept 2025
- $1,874,602,219National Blood AuthorityNational Supply arrangement for imported immunoglobulin productsPublished 4 Sept 2025
- $73,601,833National Blood AuthorityProcurement of Imported Plasma and Recombinant Products (IPRP) - IdelvionPublished 18 July 2025
- $568,838,746National Blood AuthoritySupply of imported immunoglobulin productsPublished 27 Apr 2023
- $190,469,464National Blood AuthoritySupply of Imported Plasma and Recombinant Products (IPRP)Published 27 Apr 2023
- $6,534,182National Blood AuthoritySupply of Imported Plasma and Recombinant ProductsPublished 27 Apr 2023
- $246,647,977National Blood AuthorityImported Plasma and Recombinant ProductsPublished 2 Nov 2022
- $7,567,623National Blood AuthorityImported Plasma and Recombinant Products (Factor XI Concentrate)Published 2 Nov 2022
- $3,351,400,190National Blood AuthorityNational Fractionation AgreementPublished 10 Jan 2018
| CN ID | Agency | Description | Published | Value |
|---|---|---|---|---|
| CN4235262 | Department of Defence | Pharmaceutical Products | 28 Apr 2026 | $23,279 |
| CN4233600 | Department of Defence | Pathology Products | 20 Apr 2026 | $10,346 |
| CN4194214 | Department of Defence | Pathology Products | 13 Oct 2025 | $10,346 |
| CN4190631 | Department of Defence | Pathology Products | 24 Sept 2025 | $10,346 |
| CN3743070 | National Blood Authority | National Supply arrangement for imported immunoglobulin products | 4 Sept 2025 | $1,874,602,219 |
| CN4171514 | National Blood Authority | Procurement of Imported Plasma and Recombinant Products (IPRP) - Idelvion | 18 July 2025 | $73,601,833 |
| CN3277493 | National Blood Authority | Supply of imported immunoglobulin products | 27 Apr 2023 | $568,838,746 |
| CN3383763 | National Blood Authority | Supply of Imported Plasma and Recombinant Products (IPRP) | 27 Apr 2023 | $190,469,464 |
| CN3394011 | National Blood Authority | Supply of Imported Plasma and Recombinant Products | 27 Apr 2023 | $6,534,182 |
| CN3924655 | National Blood Authority | Imported Plasma and Recombinant Products | 2 Nov 2022 | $246,647,977 |
| CN3924656 | National Blood Authority | Imported Plasma and Recombinant Products (Factor XI Concentrate) | 2 Nov 2022 | $7,567,623 |
| CN3479056 | National Blood Authority | National Fractionation Agreement | 10 Jan 2018 | $3,351,400,190 |
Sources
Department of Finance · 2013 onward · CC-BY 3.0 AU
Each row above can be verified by clicking the CN ID to view the source notice on AusTender. Methodology at /methodology/#contracts.
Refreshed 23 May 2026 · Caveats